Adverse events402

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 402

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Decreased appetite	Metabolism and nutrition disorders	GSK525762 60 mg+Abiraterone 1000 mg	4	10	4
other	Decreased appetite	Metabolism and nutrition disorders	GSK525762 60 mg Alternate+Abiraterone 1000 mg	4	6	4
other	Decreased appetite	Metabolism and nutrition disorders	GSK525762 40 mg+Abiraterone 1000 mg	4	4	6
other	Decreased appetite	Metabolism and nutrition disorders	GSK525762 80 mg+Enzalutamide 160 mg	4	10	6
other	Decreased appetite	Metabolism and nutrition disorders	GSK525762 60 mg+Enzalutamide 160 mg	9	22	15
other	Decreased appetite	Metabolism and nutrition disorders	GSK525762 60 mg Alternate+Enzalutamide 160 mg	13	21	15
other	Nausea	Gastrointestinal disorders	GSK525762 60 mg+Abiraterone 1000 mg	7	10	9
other	Nausea	Gastrointestinal disorders	GSK525762 60 mg Alternate+Abiraterone 1000 mg	3	6	3
other	Nausea	Gastrointestinal disorders	GSK525762 40 mg+Abiraterone 1000 mg	1	4	2
other	Nausea	Gastrointestinal disorders	GSK525762 80 mg+Enzalutamide 160 mg	6	10	7
other	Nausea	Gastrointestinal disorders	GSK525762 60 mg+Enzalutamide 160 mg	8	22	9
other	Nausea	Gastrointestinal disorders	GSK525762 60 mg Alternate+Enzalutamide 160 mg	11	21	17
other	Fatigue	General disorders	GSK525762 60 mg+Abiraterone 1000 mg	7	10	8
other	Fatigue	General disorders	GSK525762 60 mg Alternate+Abiraterone 1000 mg	2	6	2
other	Fatigue	General disorders	GSK525762 40 mg+Abiraterone 1000 mg	0	4	0
other	Fatigue	General disorders	GSK525762 80 mg+Enzalutamide 160 mg	3	10	3
other	Fatigue	General disorders	GSK525762 60 mg+Enzalutamide 160 mg	11	22	18
other	Fatigue	General disorders	GSK525762 60 mg Alternate+Enzalutamide 160 mg	7	21	9
other	Dysgeusia	Nervous system disorders	GSK525762 60 mg+Abiraterone 1000 mg	5	10	7
other	Dysgeusia	Nervous system disorders	GSK525762 60 mg Alternate+Abiraterone 1000 mg	2	6	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03150056/events

API reference For AI assistants

Adverse events402

Sources 3

Read this list from software.